Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 3.18%199.95B | 4.53%801.7B | 8.08%193.78B | 10.63%766.93B | 12.50%204.65B | 11.96%200.09B | 3.00%182.9B | 15.65%179.29B | 18.12%693.25B | 14.32%181.91B |
| Cost of revenue | 3.87%172.7B | 1.64%688.64B | 3.17%166.27B | 10.63%677.52B | 5.46%173.07B | 11.87%176.54B | 8.34%166.74B | 17.99%161.17B | 19.36%612.41B | 17.09%164.11B |
| Gross profit | -0.93%27.25B | 26.44%113.06B | 51.74%27.51B | 10.61%89.42B | 77.33%31.57B | 12.62%23.55B | -31.74%16.17B | -1.69%18.13B | 9.53%80.84B | -6.20%17.8B |
| Operating expense | 5.61%16.2B | 11.20%60.89B | 16.35%15.34B | 5.32%54.76B | 6.52%14.62B | 198.74%40.15B | -206.68%-13.19B | 5.70%13.19B | -0.85%52B | -1.61%13.72B |
| Operating profit | -9.19%11.05B | 50.53%52.16B | 146.21%12.17B | 20.16%34.65B | 315.28%16.96B | -322.12%-16.6B | 159.29%29.35B | -17.14%4.94B | 35.01%28.84B | -18.91%4.08B |
| Net non-operating interest income (expenses) | -4.97%363M | 16.07%1.76B | 47.49%382M | 218.32%1.51B | 139.01%533M | 232.76%386M | 275.28%334M | 451.06%259M | 302.54%475M | 3,085.71%223M |
| Non-operating interest income | 9.11%527M | 26.18%2.14B | 56.31%483M | 130.75%1.7B | 134.91%545M | 136.79%457M | 115.08%385M | 135.88%309M | 56.72%735M | 93.33%232M |
| Non-operating interest expense | 62.38%164M | 109.24%385M | 102.00%101M | -29.23%184M | 33.33%12M | -7.79%71M | -43.33%51M | -40.48%50M | -25.93%260M | -92.04%9M |
| Net investment income | -99.12%56M | -76.97%2.15B | 42.11%6.38B | 34.12%9.35B | 178.19%1.36B | 63.15%-656M | 1.98%4.17B | -29.91%4.49B | -15.68%6.97B | -153.13%-1.73B |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -97.59%387M | 20,411.39%16.05B | 19,030.38%14.96B | 23M | -154.11%-79M | -79M | ||||
| Income from associates and other participating interests | -40.57%249M | 31.95%2.38B | 30.94%419M | 84.17%1.8B | 168.00%737M | -81.10%117M | 31,350.00%629M | 285.54%320M | -15.53%979M | -16.92%275M |
| Special income (charges) | 96.78%-243M | -4.50%-7.54B | -34.90%-7.58B | 94.79%-77M | -138.54%-7.22B | -129.56%-5.62B | ||||
| Less:Other special charges | ---- | -137.08%-188M | ---- | -69.80%507M | 565.85%546M | -94.79%77M | ---- | ---- | 106.50%1.68B | 100.31%82M |
| Less:Write off | ---- | -93.87%431M | ---- | 27.04%7.03B | ---- | ---- | ---- | ---- | -22.23%5.54B | ---- |
| Other non-operating income (expenses) | 327.41%307M | 2.29%1.03B | -148.39%-135M | 192.42%1B | 154.40%68M | -55.40%157M | 117.90%499M | 346.90%279M | 3.94%343M | -128.87%-125M |
| Income before tax | -37.40%12.02B | 4.91%59.62B | 86.74%19.21B | 87.47%56.83B | 1,007.59%27.02B | 82.91%9.7B | -37.04%9.83B | -16.93%10.29B | -39.51%30.31B | -110.55%-2.98B |
| Income tax | -27.33%2.73B | -43.40%9.66B | 29.20%3.76B | 135.77%17.07B | 892.46%8.94B | 164.00%2.74B | -37.08%2.48B | -14.13%2.91B | -56.98%7.24B | -111.28%-1.13B |
| Net income | -39.85%9.29B | 25.67%49.96B | 109.47%15.44B | 72.32%39.75B | 1,077.30%18.08B | 63.10%6.95B | -37.03%7.35B | -17.99%7.37B | -30.67%23.07B | -110.15%-1.85B |
| Net income continuous operations | -39.86%9.29B | 25.66%49.96B | 109.45%15.45B | 72.31%39.75B | 1,077.83%18.08B | 63.14%6.95B | -37.03%7.35B | -17.98%7.37B | -30.67%23.07B | -110.14%-1.85B |
| Noncontrolling interests | -18.91%313M | 217.02%1.79B | 74.66%386M | -63.19%564M | -143.05%-127M | -28.32%324M | -62.18%146M | -44.61%221M | 20.06%1.53B | -30.91%295M |
| Net income attributable to the company | -40.39%8.98B | 22.91%48.17B | 110.57%15.06B | 81.96%39.19B | 949.21%18.21B | 74.02%6.63B | -36.17%7.2B | -16.76%7.15B | -32.69%21.54B | -112.04%-2.14B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -40.39%8.98B | 22.91%48.17B | 110.57%15.06B | 81.96%39.19B | 949.21%18.21B | 74.02%6.63B | -36.17%7.2B | -16.76%7.15B | -32.69%21.54B | -112.04%-2.14B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -36.23%44.24 | 29.70%224.73 | 119.73%69.37 | 83.35%173.27 | 961.65%80.65 | 75.10%29.26 | -35.74%31.79 | -16.22%31.57 | -32.66%94.5 | -111.99%-9.36 |
| Diluted earnings per share | -36.23%44.24 | 29.70%224.73 | 119.73%69.37 | 83.35%173.27 | 952.08%80.65 | 75.11%29.26 | -35.75%31.7856 | -16.22%31.57 | -32.66%94.5 | -112.12%-9.4651 |
| Dividend per share | 0 | 50.00%63 | 0 | 31.25%42 | 47.06%25 | 0 | 13.33%17 | 0 | 18.52%32 | 13.33%17 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |